FDA Publishes Final Order on AI CAD Petition
FDA issues final order denying AI CAD petition after reviewing public comments, including feedback submitted by ACR.
Read moreA group of national organizations including ACR® praised the U.S. House of Representatives for passing the Women and Lung Cancer Research and Preventive Services Act, H.R. 2319. The letter in particular thanks Reps. Brendan Boyle (D-PA) and Brian Fitzpatrick (R-PA), and Sens. Tina Smith (D-MN) and Shelley Moore Capito (R-WV), for leading the effort.
If enacted, the bill would strengthen research into how lung cancer affects women and support better screening and prevention. H.R. 2319 addresses long-standing gaps in knowledge about lung cancer among women and could help physicians deliver more effective care.
While there is a Senate companion bill, S. 1157, it has not moved out of committee or been voted on. To become law, the Senate must vote in favor of the legislation before sending it to the president for signature.
If you have questions or for more information, contact Ashley Walton, ACR Government Affairs Director.
FDA Publishes Final Order on AI CAD Petition
FDA issues final order denying AI CAD petition after reviewing public comments, including feedback submitted by ACR.
Read moreHouse Panel Reviews ACR Priorities on Medicare Reform
ACR-backed Medicare reforms advance imaging modernization, physician payment stability and reduced administrative burden.
Read moreACR Urges CMS Transparency in 2027 Physician Fee Rule
ACR submitted comments on the 2027 Medicare Physician Fee Schedule, calling for transparency in payment policy changes.
Read more